Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure (NCT06526195)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart failure patients who are not dependent on intravenous inotrope.
Who can join: Review the eligibility criteria below.
Location: Banner-University Medical Center Phoenix — Phoenix, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (68 Sites)
Showing the first 25 of 68 sites.
- Banner-University Medical Center Phoenix — Phoenix, Arizona
- Baptist Health Medical Center — Little Rock, Arkansas
- Sutter Medical Center — Sacramento, California
- University of California at San Francisco — San Francisco, California
- Washington Hospital Center — Washington D.C., District of Columbia
- Shands at the University of Florida — Gainesville, Florida
- Cleveland Clinic Florida — Weston, Florida
- Piedmont Heart Institute — Atlanta, Georgia
- Piedmont Augusta Hospital — Augusta, Georgia
- WellStar Kennestone Hospital — Marietta, Georgia
- University of Chicago — Chicago, Illinois
- Advocate Health & Hospitals Corporation — Oakbrook Terrace, Illinois
- St. Vincent Hospital — Indianapolis, Indiana
- University of Iowa Hospitals & Clinics — Iowa City, Iowa
- Kansas University Medical Center — Kansas City, Kansas
- University of Kentucky — Lexington, Kentucky
- Norton Hospital — Louisville, Kentucky
- Maine Medical Center — Portland, Maine
- Massachusetts General Hospital — Boston, Massachusetts
- Henry Ford Hospital — Detroit, Michigan
- Spectrum Health Butterworth Hospital — Grand Rapids, Michigan
- Minneapolis Heart Institute — Minneapolis, Minnesota
- Mayo Clinic — Rochester, Minnesota
- St. Luke's Hospital — Kansas City, Missouri
- University of Nebraska Medical Center — Omaha, Nebraska
📞 Contact the Study Coordinator
Phone: (925) 989-5982
Email: nourdine.chakouri@abbott.com
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Heart Failure
- REDUCE LAP-HFREF TRIAL — New York, New York
- Physiological Effects Ketone Ester in Heart — Cleveland, Ohio
- DASH Diet in Heart Failure Outpatients — Sacramento, California
- Cardiac Resynchronization Therapy in Previously Untreatable and High Risk Upgrade Patients — Huntsville, Alabama
- LUX-Dx TRENDS Evaluates Diagnostics Sensors in Heart Failure Patients Receiving Boston Scientific's Investigational ICM System. — Birmingham, Alabama
- A Research Study Looking Into How Ziltivekimab Works Compared to Placebo in Participants With Heart Failure and Inflammation — Alexander City, Alabama
Explore by condition: All Heart Failure clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.